Johnson & Johnson (JNJ)
234.34
+2.61
(+1.13%)
USD |
NYSE |
May 22, 16:00
234.47
+0.13
(+0.06%)
After-Hours: 20:00
Johnson & Johnson Free Cash Flow : 17.80B for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 10.37B |
| Merck & Co., Inc. | 14.12B |
| Pfizer Inc. | 9.484B |
| Bristol Myers Squibb Co. | 11.91B |
| Abbott Laboratories | 7.378B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 2.514B |
| Cash from Investing (Quarterly) | -1.04B |
| Cash from Financing (Quarterly) | 530.00M |
| Free Cash Flow Per Share (Quarterly) | 0.5991 |
| Free Cash Flow to Equity (Quarterly) | -4.189B |
| Free Cash Flow to Firm (Quarterly) | 1.830B |
| Free Cash Flow Yield | 3.12% |